{"disease":{"id":"cognitive-impairment-in-dementia","name":"cognitive impairment in dementia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04739423","title":"A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"CuraSen Therapeutics, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}